| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE249778
|
||||||||
| GSM7964065 |
uninjured Slc34a1 expressing PTECs, Tamoxifen-labeled, FACS-enriched, biol rep 1
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 | |||
| GSM7964066 |
uninjured Slc34a1 expressing PTECs, Tamoxifen-labeled, FACS-enriched, biol rep 2
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 | |||
| GSM7964067 |
uninjured Slc34a1 expressing PTECs, Tamoxifen-labeled, FACS-enriched, biol rep 3
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 | |||
| GSM7964068 |
cells activating Sox9 at 48h post-IRI, Tamoxifen at IRI, FACS-enriched, biol rep 1
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 | |||
| GSM7964069 |
cells activating Sox9 at 48h post-IRI, Tamoxifen at IRI, FACS-enriched, biol rep 2
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 | |||
| GSM7964070 |
cells activating Sox9 at 48h post-IRI, Tamoxifen at IRI, FACS-enriched, biol rep 3
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 | |||
| GSM7964071 |
cells expressing Sox9 at d14 post-IRI, Tamoxifen d10, d12 post-IRI, FACS-enriched, biol rep 1
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 | |||
| GSM7964072 |
cells expressing Sox9 at d14 post-IRI, Tamoxifen d10, d12 post-IRI, FACS-enriched, biol rep 2
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 | |||
| GSM7964073 |
cells expressing Sox9 at d14 post-IRI, Tamoxifen d10, d12 post-IRI, FACS-enriched, biol rep 3
|
SRA | 1 |
|
AGCT Core | Feb 26, 2024 |
